Clinical Trials | October 03, 2023
Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
New Board of Directors and management team at Suven Pharma also appointed
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
30 beneficiaries avail of services per minute
Subscribe To Our Newsletter & Stay Updated
